et al, for the Nordic Myeloma Study Group. Impact on survival of to autologous bone marrow transplantation in multiple myeloma. Bone Marrow Transplant

A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma. NMSG 20#13 A phase II study of carfilzomib-cyclophosphamide-dexamethasone and high-dose melphalan followed by randomization between observation or maintenance with carfil-zomib and dexamethasone in patients with relapsed multiple myeloma

Hanna Hodacs: ”Naturalists as Nordic Fashionistas" Seminarium: Exploiting the epigenetic vulnerabilities of multiple myeloma. Nasdaq's Economic & Statistical Research (ESR) is looking for an Analyst to join the team. The Nordic ESR team provides the Nordic & Baltic region analytical The goal of the Nordic Myeloma Study Group is to run phase II and III trials to promote better treatment of multiple myeloma. Here you can find the study protocols of all ongoing NMSG trials. Nordic Myeloma Study Group (NMSG) was established in 1987 by Nordic haematologists with a special interest in clinical myeloma research. NMSG is an independent Nordic organization of research active MDs and Norwegian, Swedish, Icelandic, Finnish, Estonian, Lithuanian, and Danish clinics / hospitals who conduct clinical myeloma research. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) Nordic Myeloma Study Group (NMSG).

2009 Oct;147(1):22-42.doi: 10.1111/j.1365-2141.2009.07807.x. The purpose of the present study was to analyse the importance and prognostic value of renal failure in multiple myeloma patients. The frequency and reversibility of renal failure in 775 multiple myeloma patients diagnosed between 1984-86 and 1990-92 in the Nordic countries were studied. title = "Nordic Myeloma Study Group, the first 15 years: Scientific collaboration and improvement of patient care", abstract = "The accomplishments of the Nordic Myeloma Study Group (NMSG) during its first 15 yr are briefly surveyed, together with a discussion of principles guiding the group's clinical trials and of problems that need to be addressed in coming years.

NMSG is an independent Nordic organization of research active MDs and Norwegian, Swedish, Icelandic, Finnish, Estonian, Lithuanian, and Danish clinics / hospitals who conduct clinical myeloma research. This website is the old website for the Nordic Myeloma Study Group, this page will no longer be updated, please go to https://www.nordicmyeloma.org/ for the new NMSG - Nordic Myeloma Study Group.

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

The accomplishments of the Nordic Myeloma Study Group (NMSG) during its first 15 yr are briefly surveyed, together with a discussion of principles guiding the group's clinical trials and of problems that need to be addressed in coming years. A secondary aim is to stimulate the building of quality registers on MM patients in the Nordic countries that do not yet have these, and creating a Nordic group with expertise in multiple myeloma and epidemiology studies. The group is open to all myeloma-interested Nordic and Baltic researchers and we are especially aiming to stimulate epidemiological research by young investigators.

av M HJORTH · Citerat av 2 — Nordic Myeloma Study Group. (NMSG) är ett nordiskt forskarnätverk, som bildades 1987. Den primära målsätt- ningen var att skapa ett större underlag.

MEDLINE and EMBASE were searched systematically for publications inEnglishfrom1950toOctober2008.Thewriting group produced the draft guideline, which was subsequently revised by consensus by the UK Myeloma Forum Executive, Writing group: On behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009) UK Myeloma Forum (UKMF Abstract. The Nordic Myeloma Study Group conducted an open randomized trial to compare bortezomib as consolidation therapy given after high-dose therapy and autologous stem cell transplantation (ASCT) with no consolidation in bortezomib-naive patients with newly diagnosed multiple myeloma. Overall, 370 patients were centrally randomly assigned 3 The full text of this article hosted at iucr.org is unavailable due to technical difficulties. A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma. NMSG 20#13 A phase II study of carfilzomib-cyclophosphamide-dexamethasone and high-dose melphalan followed by randomization between observation or maintenance with carfil-zomib and dexamethasone in patients with relapsed multiple myeloma 1996-01-15 · A randomized, controlled trial.

Lancet Oncol. 2010 Oct;11(10):973-82. doi: 10.1016/S1470-2045(10)70198-4. Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial. The Nordic Myeloma Study Group conducted an open randomized trial to compare bortezomib as consolidation therapy given after high-dose therapy and autologous stem cell transplantation (ASCT) with no consolidation in bortezomib-naive patients with newly diagnosed multiple myeloma. The effect of interferon on the health-related quality of life in multiple myeloma was assessed in two trials carried out by the Nordic Myeloma Study (Group (NMSG).
Laholm

Author information: (1)Department of Internal Medicine and Haematology L, University Hospital, Copenhagen, Denmark.

chairman.
Starta bankid på ny telefon

This website is the old website for the Nordic Myeloma Study Group, this page will no For patients we recommend the links to the national myeloma websites

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): Guidelines for the investigation of newly detected M-proteins and the management of Monoclonal Gammopathy of Undetermined Significance (MGUS) This is a joint guideline produced by the UK Myeloma Forum and Nordic Myeloma Study Group. It discusses: When to test for an M protein Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial How is Nordic Myeloma Study Group abbreviated? NMSG stands for Nordic Myeloma Study Group. NMSG is defined as Nordic Myeloma Study Group somewhat frequently.

Tullare

5 Nov 2010 with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a assigned to pamidronate 30 mg or 90 mg (252 in each group).

MM_allo_Nordic_recommendations-2017-3.pdf. The Danish Myeloma Study Group(DMSG) provides up to date evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease. Please, visit DMSG’s homepage for download of the guidelines (in Danish).